EFFICO TONIC

Страна: Ірландія

мова: англійська

Джерело: HPRA (Health Products Regulatory Authority)

Активний інгредієнт:

THIAMINE HYDROCHLORIDE ; CAFFEINE ; NICOTINAMIDE ; GENTIAN COMPOUND INFUSION

Доступна з:

Forest Laboratories UK Ltd

Код атс:

A11

ІПН (Міжнародна Ім'я):

THIAMINE HYDROCHLORIDE ; CAFFEINE ; NICOTINAMIDE ; GENTIAN COMPOUND INFUSION

Дозування:

0.18/20.20/2.10/0.31 Milligram

Фармацевтична форма:

Oral Solution

Тип рецепту:

Product not subject to medical prescription

Терапевтична области:

VITAMINS

Статус Авторизація:

Not Marketed

Дата Авторизація:

1992-11-27

Характеристики продукта

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Effico Tonic, Oral Solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Excipients: Each 5 ml dose contains ethanol 90mg and sucrose 2g.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral Solution.
Clear colourless/light straw coloured slightly viscous oral solution.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As an adjunct during convalescence, especially in the aged.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults: 10ml immediately before meals, three times a day.
Children: 2.5 to 5 ml immediately before meals three times a day.
If preferred Effico Tonic can be diluted with water.
4.3 CONTRAINDICATIONS
Use in patients who are hypersensitive to any of the ingredients.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
None stated.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None stated.
4.6 FERTILITY, PREGNANCY AND LACTATION
This product should not be used in pregnancy.
Each 5 ml oral solution contains:
Thiamine Hydrochloride
0.18
mg
Caffeine
20.20
mg
Nicotinamide
2.10
mg
Compound Gentian Infusion
0.31
ml
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_4_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_2_
_C_
_R_
_N_
_ _
_2_
_1_
_2_
_0_
_9_
_8_
_9_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
None stated.
4.8 UNDESIRABLE EFFECTS
None stated.
4.9 OVERDOSE
None stated.
5 PHARMACOLOGICAL PROPERTIES
5.1 PHARMACODYNAMIC PROPERTIES
Caffeine is a